Charles D. Blanke
- Gastroenterology top 0.01%
- Gastrointestinal Tumor Research and Treatment 60
- Oncology top 0.1%
- Colorectal Cancer Treatments and Studies 98
- Cancer Treatment and Pharmacology 26
- Pulmonary and Respiratory Medicine top 0.05%
- Gastric Cancer Management and Outcomes 78
- Lung Cancer Treatments and Mutations 29
- Sarcoma Diagnosis and Treatment 21
- Hepatology top 0.5%
- Surgery top 0.2%
-
- Genetic factors in colorectal cancer 40
-
- Cancer Genomics and Diagnostics 31
- Co-authors
- Margaret von MehrenGeorge D. DemetriMichael C. HeinrichChristopher L. CorlessChristopher D.�M. FletcherBurton EisenbergHeikki JoensuuJonathan A. Fletcher
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Charles D. Blanke
279 papers receiving 18.0k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Gastroenterology 6.5k
- Oncology 8.5k
- Pulmonary and Respiratory Medicine 9.6k
- Hepatology 1.5k
- Surgery 5.8k
Countries citing papers authored by Charles D. Blanke
This map shows the geographic impact of Charles D. Blanke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles D. Blanke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles D. Blanke more than expected).
Fields of papers citing papers by Charles D. Blanke
This network shows the impact of papers produced by Charles D. Blanke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles D. Blanke. The network helps show where Charles D. Blanke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles D. Blanke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 7 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 5 | |
| 9 | 2023 | 15 | |
| 10 | 2022 | 10 | |
| 11 | 2020 | 13 | |
| 12 | 2020 | 19 | |
| 13 | 2020 | 8 | |
| 14 | 2019 | 44 | |
| 15 | 2016 | 60 | |
| 16 | 2014 | 210 | |
| 17 | Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resectionbreakdown → | 2012 | 591 |
| 18 | 2012 | 32 | |
| 19 | 2004 | 55 | |
| 20 | Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumorbreakdown → | 2003 | 1719 |
About Charles D. Blanke
Charles D. Blanke is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 292 papers that have together received 18.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (98 papers), Gastric Cancer Management and Outcomes (78 papers), Gastrointestinal Tumor Research and Treatment (60 papers), Genetic factors in colorectal cancer (40 papers), Cancer Genomics and Diagnostics (31 papers), Lung Cancer Treatments and Mutations (29 papers), Cancer Treatment and Pharmacology (26 papers) and Sarcoma Diagnosis and Treatment (21 papers). The work is most often cited by research in Gastroenterology (6.5k citations), Oncology (8.5k citations) and Pulmonary and Respiratory Medicine (9.6k citations). Charles D. Blanke has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Margaret von Mehren, George D. Demetri, Michael C. Heinrich, Christopher L. Corless, Christopher D.�M. Fletcher, Burton Eisenberg, Heikki Joensuu, Jonathan A. Fletcher, Leonard B. Saltz and Malcolm J. Moore. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer, JAMA Oncology and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.